Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/5/26 17:12 | 10/5/26 | RPRX | Health | Drug | Pharmaceutical Preparations | Urist Marshall | NY | O | EVP,Rese | 16 | S | -12,543 | 42.24 | 0 | -297 | 228 | D | |||||||||||||||
9/24/26 16:10 | 9/22/26 | RPRX | Health | Drug | Pharmaceutical Preparations | Hite Christopher | NY | O | EVP,CB,P | 4 | S | -27,355 | 56.99 | 0 | -480 | 629 | I | |||||||||||||||
8/17/26 17:01 | 8/13/26 | RPRX | Health | Drug | Pharmaceutical Preparations | Coyne Terrance P. | NY | O | EVP,CFO | 14 | S.m | -38,956 | 42.79 | 0 | -910 | 829 | I | |||||||||||||||
5/15/26 16:37 | 8/11/25 | RPRX | Health | Drug | Pharmaceutical Preparations | Norden Gregory | NY | D | 2 | S.d | -1,375 | 37.63 | 0 | -37 | 195 | D | ||||||||||||||||
12/19/25 17:24 | 12/17/25 | RPRX | Health | Drug | Pharmaceutical Preparations | Lloyd George W. | NY | O | EVP,Inve | 3 | S.m | -13,808 | 38.85 | 0 | -355 | 1,000 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |